ADC Therapeutics S.A. (ADCT)
$1.73+8.81%Close
BUYRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $220M
- Beta
- 1.86
- P/E (TTM)
- -1.92
- Short % float
- 7.09%
- Days to cover
- 4.4
- SI change
- +27.9%
- 1W
- +53.10%
- 1M
- +55.86%
- vs SPY 1W
- +51.94%
- vs SPY 1M
- +52.86%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ADCT?
- LOPJLB’s latest quantitative signal on ADC Therapeutics S.A. (ADCT) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is ADCT in?
- ADC Therapeutics S.A. (ADCT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does ADC Therapeutics S.A. (ADCT) do?
- ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being evaluated in multiple clinical trials: a Phase II study for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; a Ph…